| 成交量 | 成交金 | 成交价 | 相对当日收盘 | | | | --- | --- | --- | --- | --- | --- | | （万 | 额（万 | 格 | 折溢价（%） | 买方营业部 | 卖方营业部 | | 股） | 元） | （元） | | | | | 48.50 | 1496.71 | 30.86 | 9.98 | 华泰证券股份有限公司上海 奉贤区望园南路证券营业部 | 中信建投证券股份有限公 司上海市华灵路证券营业 | | | | | | | 部 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 证券时报·数据宝统计显示，泰坦科技今日收盘价为28.06元，上涨0.79%，日换手率为2.76%，成交额为 1.27亿元，全天主力资金净流出81.71万元，近5日该股累计下跌3.57%，近5日资金合计净流出3962.39万 元。 两融数据显示，该股最新融资余额为2.74亿元，近5日减少65.62万元，降幅为0.24%。（数据宝） 8月13日泰坦科技大宗交易一览 泰坦科技8月13日大宗交易平台出现一笔成交，成交量48.50万股，成交金额1496.71万元，大宗交易成交 价为3 ...

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | | 2025-08-13 | 泰坦科技 | 688133 | 30.86 1496.71 48.5 | 华泰证券股份有限 | 中信建投证券股份 | | | | | | 公司上海奉贤区望 | 有限公司上海市华 | | | | | | 日三十九十六名世 | 月三世井工資印 | 8月13日，泰坦科技大宗交易成交48.5万股，成交额1496.71万元，占当日总成交额的10.54%，成交价30.86元，较市场收盘价28.06元溢价9.98%。 ...

Group 1 - Titan Technology (688133) closed at 27.9 yuan on August 8, 2025, down 2.79% with a turnover rate of 3.15% and a trading volume of 51,800 lots, amounting to 145 million yuan [1] - The latest quarterly report shows total revenue of 604 million yuan, a year-on-year decrease of 9.07%, while net profit attributable to shareholders was 5.13 million yuan, an increase of 122.27% [1] - The company has a current ratio of 2.158, a quick ratio of 1.388, and a debt-to-asset ratio of 40.76% [1] Group 2 - Titan Technology has made investments in 37 companies and participated in 2,083 bidding projects [2] - The company holds 42 trademark registrations and 244 patents, along with 70 administrative licenses [2]

Core Viewpoint - A total of 16 A-share listed companies disclosed their latest merger and acquisition announcements during the week of July 21 to July 27, with notable transactions including Huylin Ecological's plan to acquire a 49% stake in Wuhan Junheng, and the resumption of trading for its stock on July 28 [1][3]. Group 1: Company Announcements - Huylin Ecological announced on July 25 its intention to purchase a 49% stake in Wuhan Junheng, with its stock set to resume trading on July 28 [3]. - Western Gold announced on July 25 its plan to acquire 100% of Xinjiang Meisheng for 1.655 billion yuan [3]. - Guochuang High-tech announced on July 25 its plan to acquire 100% of Ningbo Guopei for 22.5 million yuan [3]. - Shanghai Pharmaceuticals announced on July 25 its intention to acquire a 10% stake in a financial company held by Shashi Dongtan [3]. - Heng Rui Medicine announced on July 25 its plan to acquire a 1.4587% stake in Chengdu Shengdi Medicine for 4.0144 million yuan [3]. - Yuanli Co. announced on July 24 its intention to purchase 100% of Tongsheng Co., with its stock set to resume trading [3]. - Angel Yeast announced on July 24 its plan to acquire a 55% stake in Zuitong Sugar Industry for 506 million yuan [3]. - Jinlong Co. announced on July 23 its intention to acquire a 29.32% stake in Zhisuang Company [3]. - Huayu Mining announced on July 23 its plan to acquire an 11% stake in Asia Pacific Mining for 300 million yuan [3]. - Titan Technology announced on July 23 its intention to acquire 100% of ASL for approximately 55.85 million yuan [3]. - GoerTek announced on July 22 its plan to acquire Mia Precision Technology Co. and Changhong Industrial Co. for approximately 10.4 billion Hong Kong dollars [3]. - Geer Software announced on July 22 its intention to acquire more than 51% of Weipin Zhiyuan, which owns an intelligent orchestration platform [3]. - Tianrun Industrial announced on July 22 its plan to acquire 100% of Shandong Altai for 13.5 million yuan [3]. - Hanyi Co. announced on July 22 its intention to acquire a 39% stake in Shanghai Pidong Cultural Media for 10.2 million yuan [3]. - ST Xifa announced on July 21 its plan to cash purchase a 50% stake in Lhasa Beer held by Carlsberg, which is expected to constitute a major asset restructuring [3]. - Beiding Co. announced on July 21 its intention to acquire 100% of Zhongshan Kairui for 156 million yuan [3].

Core Viewpoint - Titan Technology (688133) has seen a stock price increase of 8.73% this week, closing at 27.4 yuan, with a total market capitalization of 4.506 billion yuan [1] Company Announcement Summary - Titan Technology plans to acquire 100% equity of Apollo Scientific Ltd. (ASL) for approximately 55.85 million yuan to expand its overseas sales channels [1] - The acquisition involves a payment of 5,756,429 GBP, which is about 55.85 million yuan, and is not classified as a related party transaction or a major asset restructuring [1] - ASL reported a revenue of 87.09 million yuan and a net loss of 5.5 million yuan for the year 2024 [1] - The transaction is subject to approval from relevant national and local authorities and will be included in the company's consolidated financial statements upon completion [1] - The acquisition is expected to enhance the company's core competitiveness and diversify its product line [1]

Core Viewpoint - Shanghai Titan Technology Co., Ltd. announced the acquisition of 100% equity in Apollo Scientific Ltd. for £5,756,429, approximately RMB 55.85 million, aiming to enhance its international presence and product offerings [1][2]. Group 1 - The acquisition will allow Titan to expand its overseas channels and enrich its product line [2]. - Apollo Scientific Ltd. specializes in manufacturing and supplying aromatic, heterocyclic, and aliphatic compounds, including fluorinated compounds and life science reagents [1][2]. - The company is known for its high-quality products, inventory levels, rapid delivery times, and exceptional customer service, supporting clients at every stage of the R&D process [1][2]. Group 2 - Apollo Scientific was established in 1993 and has gradually expanded its business through sales and marketing for small international manufacturers in the UK and Europe [2]. - The transaction is expected to improve supply chain efficiency and profitability through synergies [2].

Group 1 - Titan Technology plans to acquire 100% of Apollo Scientific Ltd. for approximately 55.85 million yuan, enhancing its global supply chain and competitiveness in the reagent field [1] - Qianjin Pharmaceutical has received registration certificates for two drugs, enriching its product line and strengthening its position in the treatment of vitamin B12 deficiency and heart failure [2] - Meizhong Jiahe intends to raise approximately 270 million HKD through a share placement, focusing on hospital construction, medical AI, and operational funding [3] Group 2 - ST Weiming has successfully recovered 100% equity of Xiamen Weiming, resolving long-standing equity disputes and stabilizing corporate governance [4] - Guangji Pharmaceutical has been fined 1.5 million yuan for information disclosure violations, highlighting governance issues and the need for compliance to restore investor confidence [5]

Group 1 - Rongzhi Rixin expects a net profit increase of 2,027.62% to 2,179.59% for the first half of 2025, with projected profits between 14 million to 15 million yuan [1] - The significant profit growth is attributed to the acceleration of digital and intelligent transformation across industries, leading to increased revenue from sectors like wind power and petrochemicals [1] - The company has improved operational management efficiency, resulting in enhanced gross margins and overall profitability [1] Group 2 - Jinzhai Food plans to repurchase shares worth between 50 million to 100 million yuan, with a maximum repurchase price of 16 yuan per share [2] - The repurchase will be funded through self-owned funds and a special loan from China Merchants Bank, with a loan commitment of up to 90 million yuan [2] Group 3 - Zhongfu Information's chairman and general manager, Wei Dongxiao, has been detained, and the board has arranged for the deputy general manager to assume his responsibilities during this period [3][4] - The company states that this situation will not significantly impact its daily operations [4] Group 4 - Shenzhen Energy plans to invest approximately 789.703 million yuan in the construction of the Honghaiwan offshore wind power project, with a portion funded through financing [6] - The company will increase its capital in its subsidiary by 153.108 million yuan to support this project [6] Group 5 - *ST Zitian faces potential delisting due to failure to rectify false financial reporting as mandated by the China Securities Regulatory Commission [8] - The company has not disclosed corrected financial reports within the required timeframe, leading to a warning of delisting risk [8] Group 6 - Watson Bio has signed a strategic cooperation framework agreement with Yuxi State-owned Capital Operation Co., aiming to establish a long-term partnership in the vaccine and bioproducts industry [10] - The collaboration is expected to enhance innovation and business expansion in the vaccine sector [10] Group 7 - Weiming Environmental reported a total power generation of 226,162.29 million kWh in the first half of 2025, representing a year-on-year increase of 7.54% [12] - The company also recorded a total waste input of 689.32 million tons, with a growth of 8.71% compared to the previous year [12]

Group 1 - Industrial and Commercial Bank of China plans to redeem $2.9 billion of overseas preferred shares, with the redemption scheduled for September 23, 2025 [1] - Everbright Bank's stake held by CITIC Financial Asset Management increased from 7.08% to 8% after acquiring 264 million A-shares and 279 million H-shares [1] - Weiming Environmental reported a 7.54% year-on-year increase in electricity generation, totaling 2.262 billion kWh in the first half of 2025 [1] Group 2 - Tiancheng Automation announced that Yunnan Trust plans to reduce its stake by up to 1%, equating to a maximum of 3.971 million shares [2] - Baobian Electric revealed that the Equipment Finance Group intends to reduce its stake by up to 1%, or 18.4153 million shares [3] Group 3 - Titan Technology plans to acquire 100% of Apollo Scientific Ltd. for approximately 55.85 million yuan to expand its overseas sales channels [4] - China Communication Signal announced winning seven significant projects in the rail transit market, with a total bid amount of approximately 1.431 billion yuan [5] Group 4 - Rongzhi Rixin expects a net profit increase of 2027.62% to 21.7959 million yuan for the first half of 2025, driven by digital and intelligent transformation in various industries [6] Group 5 - Sanmu Group is facing three lawsuits from Fuzhou Rongtou over a sales contract dispute, with the total amount in question being approximately 107 million yuan [8] - Sanfu Outdoor received approval from the China Securities Regulatory Commission for a specific stock issuance [8] - Jin Zai Foods plans to repurchase shares worth between 50 million and 100 million yuan for employee incentive plans [8] - Supor reported a slight decline in net profit to 940 million yuan for the first half of 2025, despite a revenue increase of 4.68% [8] Group 6 - Watson Bio signed a strategic cooperation framework agreement with Yuxi State-owned Capital Operation Company to enhance collaboration in the vaccine and bioproducts industry [9] - Qidi Design, as the lead of a consortium, won a bid for the Henan Airport Intelligent Computing Center project, with a construction bid of 860 million yuan [10] Group 7 - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [11] - Matrix Co. reported new orders worth 272 million yuan in the second quarter for its decoration business, with total uncompleted orders amounting to 677 million yuan [12] - Beixin Road and Bridge's subsidiaries won contracts totaling 1.629 billion yuan for highway projects, which could positively impact future performance [12]

Core Viewpoint - Shanghai Titan Technology Co., Ltd. plans to acquire 100% equity of Apollo Scientific Ltd. from Central Glass Japan for £5,756,429, aiming to enhance its international presence and core competitiveness [1][2][3]. Group 1: Investment Overview - The company intends to use its own or self-raised funds for the acquisition, which is not classified as a related party transaction or a major asset restructuring [1][4]. - The transaction is part of the company's strategic plan to expand overseas sales channels and accelerate internationalization [2][3]. Group 2: Transaction Details - The acquisition will result in Apollo Scientific Ltd. being included in the company's consolidated financial statements as a subsidiary [3]. - The transaction is subject to approval from relevant national and local authorities, and the company has authorized its management to handle the necessary procedures [4][5]. Group 3: Target Company Information - Apollo Scientific Ltd. is a private limited company registered in England, primarily engaged in the distribution and customized services of chemical products [6][7]. - The financial performance of Apollo Scientific Ltd. shows a revenue of £8.71 million in 2024 and a net loss of £0.55 million, with total assets of £11.55 million and total liabilities of £0.96 million [7][8]. Group 4: Strategic Benefits - The acquisition is expected to enhance the company's sales and warehousing systems, facilitating faster responses to overseas customer demands and expanding its global reach [3][8]. - The integration of Apollo Scientific Ltd. is anticipated to improve procurement channels and optimize costs, thereby enhancing profitability [3][8]. Group 5: Due Diligence and Valuation - The company has engaged professional institutions for legal and financial due diligence, ensuring compliance and risk assessment related to the transaction [8][9]. - The purchase price was determined based on the target company's net assets and potential business synergies, amounting to £5,756,429 (approximately ¥55.85 million) [8][9].